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Endomyocardial   fibrosis   (EMF)   is   a   distinct   obliterative   cardiomyopathy   characterized 
anatomically by right/left/bi ventricular endocardial fibrotic thickening and varying degrees of 
obliteration of the ventricular cavity. Chamber obliteration leads to diastolic restriction to 
ventricular filling and thus diastolic ventricular dysfunction.   Involvement of the chordae 
tendinae and papillary muscles in the fibrotic process results in atrioventricular (AV) valve 
regurgitation. The ventricular endocardial thickening is predominantly at apex leading to apical 
obliteration. When it extends to the inflow, papillary muscles and chordae are involved and AV 
valve regurgitation ensues. The hemodynamics is that of a restrictive cardiomyopathy with 
varying degrees of AV valve regurgitation.                                                                                       
            
Though Arthur Williams and Davis [1,2] described LV fibrosis with mitral valve incompetence 
as early as 1938 and 1948 respectively in Uganda, the first autopsy report of EMF in India by 
Samuel and Anklesaria [3] in Kerala by Gopi came as late as in 1960 and 1962 respectively. 
The diagnosis was clinical and hence the patients were diagnosed late in the course of their 
disease. Even though electrocardiaogram (ECG) was available, the lack of sensitivity and 
specificity of ECG in diagnosis as well as prognostication relegated its role as a useful clinical 
tool. However with the advent of hemodynamic and angiographic diagnostic facilities, the 
disease   was   more   reliably   and   accurately   diagnosed   and   the   disease   spectrum   better 
characterized, including grades of cavity obliteration and AV valve regurgitation of the right 
ventricular (RV), left ventricular (LV) or both [4,5]. Availability of echocardiography made  
non-invasive diagnosis and hemodynamic assessment of EMF easy, and  an occasional patient 
was detected to have asymptomatic EMF or EMF associated with other acquired heart diseases. 
Magnetic  resonance cardiac  imaging  further refined appreciation  of fibrotic  endocardial 
involvement in EMF.                                                                                           
ECG abnormalities or ECG changes paralleling the extent of obliteration and AV valve 
regurgitation and resulting  hemodynamic derangement has not been systematically studied. We 
will discuss briefly the structural abnormality and the consequent hemodynamic abnormality, 
and the associated ECG abnormalities of EMF.                                                                           
RV EMF results in RV diastolic dysfunction and tricuspid valve incompetence. It also results in 
a distorted and often contracted RV cavity and RA enlargement due to RV diastolic dysfunction 
and or tricuspid valve incompetence.                                                                           
Moderate to large pericardial effusion is common in severe forms of RV EMF with severe 
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tricuspid incompetence and heart failure. The ECG often suggests right atrial (RA) abnormality,  
reflecting  RA pressure and volume overload . ECG abnormality includes peaking and increased 
P wave amplitude in lead II and rarely tall peaked and narrow positive P waves resembling the 
Himalayan P waves of Ebstein's anomaly. Often we have observed   QR pattern with a 
diminutive R wave in lead V1 (Figure 1),  attributed to RA enlargement, though this pattern is 
seen even in patients with atrial fibrillation (AF)  (Figure 2). In a recent study of ECG in 
isolated RV EMF, we noted  a dominant R wave in V2 in the absence of QR pattern in V1 in 14 
of 25 patients resulting in early transition from a dominant S wave in right sided chest leads  to 
dominant R wave in V2 or earlier  (Figure 3). Atrial arrhythmias are common and AF is the end 
stage atrial rhythm in most patients with advanced RV EMF. It is noteworthy that patients with 
RV EMF and AF rarely have fast ventricular response, in striking contrast to patients with AF 
and LV EMF. Patients with large pericardial effusion often have low voltage QRS, satisfying 
the low voltage ECG criteria.  
Figure 1.  Patient with RVEMF: QR pattern in V1, peaked P wave in lead II
LV EMF is characterized by varying degrees of endocardial obliteration generally limited to the 
endocardium and only secondary effects on myocardium and no pericardial involvement. 
Morphologically, LV hypertrophy is uncommon and the cavity dilates in the transverse axis to 
accommodate the increased preload resulting from mitral incompetence. The fibrotic areas can 
calcify and endocardial calcification with a contracted LV cavity is highly specific for EMF. 
The electrocardiogram reflects the hemodynamic abnormality. Left atrial (LA) abnormality in 
ECG parallels the diastolic dysfunction and degree of mitral incompetence. AF occurs in 
advanced and uncorrected case of LVEMF. The odd finding is a uniform ST segment depression 
and T wave inversion more evident in the lateral chest leads, similar to apical hypertrophic 
cardiomyopathy (HCM) and non- ST elevation acute coronary syndromes (Figure 4). The ECG 
and echocardiographic abnormalities of severe LV EMF and Apical HCM closely resemble one 
another.   Endocardial   calcification,  plastering   of posterior   mitral   leaflet   to  posterior   LV 
endocardium  and AV valve incompetence favour LV EMF. Not uncommonly, nonspecific ST 
T wave abnormalities in the precordial leads in a routine ECG evaluation brings these patients to 
clinical attention for further evaluation to exclude coronary heart disease and LVEMF is 
diagnosed during   echocardiographic study or LV angiogram. Patients with LVEMF and 
resultant pulmonary hypertension leads to have features of RV hypertrophy and right ward 
frontal plane QRS axis deviation. Ventricular tachycardia and sudden death attributable to 
malignant ventricular arrhythmia is rare. 
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Figure 2.  Patient with RV EMF: AF and qR in V1
Figure 3.  Patient with RVEMF: Early transition of QRS at V2 
More than 50% patients with EMF have biventricular involvement and the ECG reflects  a 
combination of these abnormalities. ECG findings reported  by Balakrishnan et al [6] from Sree 
Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum  (210 patients) in 
1991 included AF (33%), junctional rhythm or heart block (4.4%), right axis deviation (29%), 
intra ventricular conduction abnormality (16%) and atrial tachycardia or atrial flutter(3.5%)6. 
Earlier three large studies of 60 patients, 95 patients and 50 patients, reported AF in 40%, 
junctional rhythm in 2%, RA enlargement in 32% and QR pattern in V1 in 25% patients [7-9]. 
LA enlargement was common in patients with LVEMF and 18% of LVEMF patients had LVH 
(left ventricular hypertrophy)  with strain [9].
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Figure 4.  Patient with LV EMF: LVH with strain  and LAE
Electrophysiological abnormalities  in EMF have not been widely studied. In 1990, we 
conducted electrophysiological studies in 18 patients with EMF who were in sinus rhythm. The 
important findings included, lower AV Wenkebach heart rate on incremental atrial pacing, mild 
increase in AH interval and a normal HV interval except in one patient (HV interval 70 ms). 
Interestingly, the atria had pockets of low voltage splintered atrial activity (electrical myopathy 
of RA as a fore runner to atrial arrhythmias and AF). The injury potentials obtained from the 
RV endocardium had low voltages corresponding to areas of fibrotic  endocardial involvement. 
The pacing threshold at the fibrotic areas  was surprisingly within normal range [10].          
Incidence of complete heart block (CHB) or sick sinus syndrome (SSS) necessitating pacing is 
rare in EMF. We had 3 patients with RV EMF and CHB requiring pacing. The two patients seen 
in the Eighties, had epicardial pacing after failure to obtain stable pacing with tined lead in the 
RV due to lack of trabeculae. Subsequently, endocardial active fixation lead was used  in the 
third patient with acceptable pacing threshold. SSS patients are offered dual chamber or VVI 
pacing using active fixation leads. In   RVEMF patients,   AF does not result in a rapid 
ventricular response unlike in LVEMF. Patients subjected to surgery presently also undergo RA 
reduction surgery to facilitate maintenance of sinus rhythm.                                                 
We have observed a significant reduction in patients with a new diagnosis of EMF over the past 
2 decades [11]. The newly diagnosed patients are older, less symptomatic, have less severe form 
of the disease, are often diagnosed when evaluated for non specific symptoms and ST T wave 
abnormality in ECG, and have excellent medium term prognosis (<10% mortality  in 7 years). 
ECG is neither specific nor sensitive for the diagnosis of EMF but  in the last decade, many 
patients have been diagnosed as LVEMF  during investigation for non specific ST T changes in 
ECG.  
EMF remains an enigma for want of an etiopathogenic explanation. The incidence appears to be 
decreasing and end stage EMF is rarely seen now. Less affected patients are often diagnosed 
when evaluated for non specific symptoms and an abnormal  ECG. ECG is neither sensitive nor 
specific  to   rule  in   or  rule  out   EMF  and   meticulous  echocardiographic  examination  is 
investigation of choice to detect milder forms of EMF.  
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